Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study.
- DOI
- 10.1111/bjh.70614
- Published
- 2026 Aug
- Container
- British journal of haematology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bjh.70614,
title = {Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study.},
author = {Ceriani L and Milan L and Cascione L and Di Rocco A and Kryachok I and Davies AJ and Stathis A and Rossi D and Johnson PWM and Martelli M and Zucca E},
year = {2026},
journal = {British journal of haematology},
doi = {10.1111/bjh.70614},
url = {https://doi.org/10.1111/bjh.70614}
}RIS
TY - JOUR TI - Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study. AU - Ceriani L AU - Milan L AU - Cascione L AU - Di Rocco A AU - Kryachok I AU - Davies AJ AU - Stathis A AU - Rossi D AU - Johnson PWM AU - Martelli M AU - Zucca E PY - 2026 JO - British journal of haematology DO - 10.1111/bjh.70614 UR - https://doi.org/10.1111/bjh.70614 ER -
APA
L, C., L, M., L, C., A, D. R., I, K., AJ, D., A, S., D, R., PWM, J., M, M., & E, Z. (2026). Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study.. British journal of haematology. https://doi.org/10.1111/bjh.70614
Source records
- pubmed · retrieved 2026-09-25T03:19:02.018Z